SCIENTIFIC ADVISORY BOARD
Brook Brouha, M.D., Ph.D.
Dr. Brook Brouha is a board-certified Dermatologist and Dermatopathologist. Dr. Brouha completed his dermatology residency training at the University of California at San Diego and dermatopathology fellowship at the University of Texas Southwestern Medical Center. He received his pHD in genetics form the University of Pennsylvania and his medical degree from the University of Pennsylvania School of Medicine and. Dr. Brouha is a fellow of the American Academy of Dermatology, a member of the prestigious Noah Worcester Dermatological Society and has served on the board of the Pacific Dermatology Association. Dr. Brouha has also published numerous articles in peer review professional journals.
Laura Ferris, M.D., Ph.D.
Laura Korb Ferris, MD, PhD is an Associate Professor and Director of Clinical Trials at the University of Pittsburgh Department of Dermatology. She is a member of the University of Pittsburgh Cancer Institute melanoma program where directs the pigmented lesions clinic. Dr. Ferris has been an investigator on several clinical trials evaluating technologies and assays for melanoma early detection and predictors of outcome in patients with melanoma. Her research, which is primarily focused on melanoma epidemiology, screening, and early detection has been widely published in the peer-reviewed literature. Dr. Ferris received her PhD in immunology from The Johns Hopkins School of Medicine and her MD from The University of Maryland and she completed her residency in dermatology and fellowship in cutaneous oncology at the University of Pittsburgh.
Pedram Gerami, M.D.
Dr. Pedram Gerami is an associate professor of dermatology and pediatrics at Northwestern University and the co-director of melanoma research at the Northwestern Skin Cancer Institute. Dr Gerami is interested in the clinical, histologic and molecular genetics of melanocytic neoplasms. As a clinical dermatologist he sees patients with a history of melanoma or dysplastic nevi and as a dermatopathologist he is focused in the histopathologic evaluation of melanocytic neoplasms. He has authored over 80 peer reviewed journal articles and numerous chapters in dermatologic textbooks. His research is primarily focused on the use of molecular diagnostics to improve diagnosis and prognostication of melanocytic neoplasms. Dr Gerami received his medical degree from the Chicago Medical School and received his residency at the University of Iowa Department of Dermatology followed by a fellowship in dermatopathology at the University of Chicago.
Stevan Knezevich, M.D., Ph.D.
Dr. Stevan Knezevich is Board Certified in Dermatopathology, Anatomic Pathology, and Clinical Pathology. He received his MD from the University of Toronto Medical School. Prior to this, he received his PhD in Pathology from the University of British Columbia and spent an additional year as a post-doctoral fellow in Lymphoma research. His Residency and Surgical Pathology Fellowship were completed at Washington University in St. Louis, MO and his Dermatopathology Fellowship at Stanford University. Dr. Knezevich worked at the VA Medical Center and served as Assistant Professor at the University of Washington in Seattle.
Ronald Moy, M.D.
Dr. Ronald Moy is a Board Certified Dermatologist and a diplomate of the American Board of Dermatology. He is a leader in the field of dermatology as a past President of the American Academy of Dermatology, Pacific Dermatologic Association and American Society for Dermatologic Surgery and as Vice President of the Skin Cancer Foundation. Dr. Moy completed his dermatology residency training at UCLA and his Facial Cosmetic and Mohs Micrographic Surgery Fellowship training at the University of Pittsburgh Center for Health Services. He is a former professor at the David Geffen School of Medicine at UCLA, former Co-Chief of the UCLA division of Dermatology and former Chief of Dermatologic Surgery. He has served as president of the Los Angeles County Medical Association, Bay District and Editor-in-Chief of the Dermatologic Surgery Journal.
Gary Peck, M.D.
Dr. Gary Peck is a board certified dermatologist that began his career at the National Institutes of Health in the Dermatology Branch of the National Cancer Institute. He is a recipient of the Discovery Award of the Dermatology Foundation, the highest award in Dermatology in recognition of his discovery of isotretinoin for the treatment of severe, recalcitrant nodulocystic acne and other disorders, including the prevention of basal cell carcinomas.
Dr. Peck founded and served as director of the Melanoma Center at the Washington Hospital Cancer Institute, the first center of its kind in the nation’s capital. The Melanoma Center is a multi-specialty clinic that has accrued over 2000 cases of melanoma and screens hundreds of high-risk patients for the development of melanoma. Dr. Peck received his MD from the University of Michigan Medical School in Ann Arbor, Michigan. He completed his dermatology residency training at the University of Chicago Hospitals. Dr. Peck has published over 150 original articles, book chapters, and research abstracts.
Darrel Rigel, M.D.
Dr. Darrel Rigel is a Clinical Professor of Dermatology at New York University Medical Center. He received his BS and MBA from MIT and his MD degree from George Washington University. He attended Cornell University Medical Center for his Internship in Internal Medicine, and completed his training at NYU where he was Resident, Chief Resident, NIH Training Fellow and Dermatology Surgery Fellow. Dr. Rigel has served as President of the American Academy of Dermatology (1999) and for 9 years as a Director of the American Board of Dermatology. He is a Past President of the American Society for Dermatologic Surgery and the American Dermatological Association. Dr. Rigel has also received numerous honors including the American Cancer Society’s National Honor Citation for Skin Cancer Programs and Presidential Citations from the American Academy of Dermatology and American Society for Dermatologic Surgery for public education programs in skin cancer.
Daniel Siegel, M.D.
Dr. Daniel M. Siegel is a Clinical Professor of Dermatology and former Director of the Procedural Dermatology Fellowship at SUNY Downstate. He has served as president of the AAD (2012) and is a past member of both the Academy’s board of directors and Coding and Reimbursement Task Force. He is a diplomate of the American Board of Dermatology and the American Board of Laser Surgery and is a fellow of the American Society for Dermatologic Surgery (ASDS), the American Academy of Dermatology (AAD), the American College of Mohs Surgery and the American Society of Mohs Surgery. Dr. Siegel earned his medical degree from Albany Medical College in Albany, N.Y. He completed his residency in dermatology at the University of Texas Health Sciences Center at Dallas and his fellowship at the Baylor College of Medicine in Houston. Dr. Siegel also earned a Master of Science degree in management and policy from Stony Brook University, Stony Brook, N.Y.
Maral Skelsey, M.D.
Dr. Maral Skelsey is the Director of the Dermatologic Surgery Center of Washington and Clinical Professor and Director of the Dermatologic Surgery at Georgetown University Medical Center in Washington, DC. Dr. Skelsey received her medical degree from Washington School of Medicine in St. Louis, MO where she also completed her dermatology residency and served as Chief Resident. She completed her fellowship through the American College of Mohs Surgery at the University of Alabama in Birmingham. Dr. Skelsey is a fellow of the American Academy of Dermatology (AAD). She has published numerous articles in peer review professional journals. She serves as an officer of the Washington DC Dermatologic Society and is a Fellow of the American Society of Laser Medicine and Surgery, the American Society of Dermatologic Surgery and the American College of Mohs Surgery.